Legal & General Group’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Legal & General Group’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,638	Closed	-$239K	–	3437
2022 Q4	$239K	Buy	6,638 +196	+3%	+$4.9K	﹤0.01%	2544
2022 Q3	$97K	Buy	6,442 +344	+6%	+$5.58K	﹤0.01%	2837
2022 Q2	$81K	Buy	6,098 +1,926	+46%	+$30.6K	﹤0.01%	2908
2022 Q1	$80K	Buy	4,172 +1,006	+32%	+$20.9K	﹤0.01%	2916
2021 Q4	$75K	Buy	3,166 +2,257	+248%	+$52.3K	﹤0.01%	2965
2021 Q3	$18K	Buy	+909	New	+$19.5K	﹤0.01%	3322

Legal & General Group's IMGO Position: Q1 2023 in Review

Legal & General Group sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 6,638 shares — an estimated $239K sold.

Legal & General Group first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $239K in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Legal & General Group reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Legal & General Group sold 6,638 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $239K.
Legal & General Group first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Legal & General Group's Imago BioSciences, Inc. Common stock position peaked at $239K in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Legal & General Group's 13F filing for Q1 2023, filed 15 May 2023.